Search
for
Sort by
Research 511–540 of 1000+
- A Cell Membrane-Level Approach to Cicatricial Alopecia Management: Is Caveolin-1 a Viable Therapeutic Target in Frontal Fibrosing Alopecia?
- Steroid Hormones
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- A Review and Meta-Analysis of the Prevalence and Health Impact of Polycystic Ovary Syndrome Among Medical and Dental Students
- Open-label placebos reduce hair cortisol concentrations and psychological distress - a randomized controlled trial
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Hyperandrogenemia in an ethnically heterogeneous cohort of Midwestern United States diabetic gestations
- Screening for 21-hydroxylase–deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Understanding Polycystic Ovary Syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The Neurobiology of Sexual Function
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Dermatologic manifestations of endocrine disorders
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- Idiopathic Hirsutism*
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Endocrine-skin interactions
- Androgens and Antiandrogens
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Interventions for female pattern hair loss
- Treatment strategies for alopecia
- Androgenic Hormone Profile of Adult Women with Acne